NDUFA11
protein-codingNADH:ubiquinone oxidoreductase subunit A11, the group of NADH:ubiquinone oxidoreductase supernumerary subunits|Tim17 family
Gene summary
This gene encodes a subunit of the membrane-bound mitochondrial complex I. Complex I is composed of numerous subunits and functions as the NADH-ubiquinol reductase of the mitochondrial electron transport chain. Mutations in this gene are associated with severe mitochondrial complex I deficiency. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~12.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032619
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0044970
Submitter: ClinGen
The relationship between *NDUFA11* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of February 17, 2022. The *NDUFA11* gene encodes a subunit of complex I of the mitochondrial respiratory chain. The *NDUFA11* gene was first reported in relation to autosomal recessive primary mitochondrial disease in 2008 (PMID: 18306244). While various names have been given to the constellation of features seen in those with *NDUFA11*-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the *NDUFA11* phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included one splice region variant that was reported in a homozygous state in three consanguineous Israeli Bedouin families from one publication (PMID: 18306244). RT-PCR from cDNA from patients’ fibroblasts demonstrated a shorter transcript as well as the wild-type transcript, and enzymatic studies from isolated muscle mitochondria showed reduced complex I activity in the three probands (PMID: 18306244). Affected individuals from two families had a fatal infantile lactic acidosis while individuals in the third family had developmental delay, microcephaly, optic atrophy, and seizures. No segregation data were available. This gene-disease association is also supported by known functional alterations in non-patient cells and a Caenorhabditis elegans model organism (PMIDs: 24191001, 27626371, 30531981, 34106255). In summary, there is limited evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on February 17, 2022 (SOP Version 8).
Inheritance Pattern: AR
Disease ID:MONDO:0100133
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0032619
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Gastrointestinal; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Medical treatment (eg, riboflavin, ubiquinol) may be beneficial; Individuals may have cardiac involvement
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NDUFA11 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_175614.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 18 | 19 | |||
| missense | 1 | 40 | 41 | |||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 3 | |||
| Total | 1 | 3 | 42 | 18 | 0 | 64 |
Highest pathogenic variant AF is 0.0000063483913
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_783313.1 | 4 | MANE Select | |
| Ensembl | ENSP00000311740.4 | 4 | MANE Select | |
| RefSeq | NP_001180304.1 | 4 | Standard | |
| Ensembl | ENSP00000389160.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Retrograde endocannabinoid signaling - Homo sapiens (human)
- Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human)
- Alzheimer,s disease - Homo sapiens (human)
- Huntington,s disease - Homo sapiens (human)
- Thermogenesis - Homo sapiens (human)
Biological Process
- mitochondrial respiratory chain complex I assembly
- oxidation-reduction process
Cellular Component
- mitochondrion
- mitochondrial inner membrane
- mitochondrial respiratory chain complex I
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000418389
- Coding exons
- 4
- Length
- 12731
- Individuals with no LoFs
- 125699
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 2
- Defined
- 125701
- p
- 0.00000796
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.541 | 117 | 135 | 0.869 | 0.00000802 | 1409 |
| Missense (PolyPhen) | 31 | 34.753 | 0.892 | 337 | ||
| Synonymous | 0.518 | 55 | 60.1 | 0.915 | 0.00000426 | 495 |
| Loss of Function | 0.769 | 3 | 4.82 | 0.622 | 2.04e-7 | 59 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.0000088 | 0.0000088 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:27626371}.;
- Disease
- DISEASE: Mitochondrial complex I deficiency (MT-C1D) [MIM:252010]: A disorder of the mitochondrial respiratory chain that causes a wide range of clinical manifestations from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. {ECO:0000269|PubMed:18306244}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0858
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.416
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |